Topic
Paul Tredwell
News
23 Oct 2024
Accord Healthcare receives positive CHMP opinion for IMULDOSA, ustekinumab biosimilar to Stelara
Ustekinumab is a human monoclonal antibody that targets the cytokines interleukin-12 and interleukin-23 which may play an important role in…
Global News
26 Sep 2024
Intas and Henlius receive Positive CHMP Opinion for HETRONIFLY
HETRONIFLY (serplulimab) is expected to become the first anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES-SCLC Intas Pharmaceuticals announced…